Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0158182 OPHTHALMIC COMPOSITIONS CONTAINING A NITRIC OXIDE DONOR
The present invention relates to compositions comprising a 4-nitrooxybutan-1-ol alkyl ester as nitric oxide donor. More specifically, the invention relates to...
2016/0158181 Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments
Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the...
2016/0158180 Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments
Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the...
2016/0158179 NANOEMULSION THERAPEUTIC COMPOSITIONS AND METHODS OF USING THE SAME
The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are...
2016/0158178 DOSAGE FORMS AND THERAPEUTIC USES L-4-CHLOROKYNURENINE
Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurological dysfunction.
2016/0158177 NUTRITIONAL COMPOSITION FOR IMPROVING BRAIN FUNCTION IN PHENYLKETONURIA
The present invention relates to food compositions comprising nutritional composition for use in the treatment or nutritional management of phenylketonuria or...
2016/0158176 COMPOSITIONS AND METHODS OF USING MODIFIED RELEASE SOLABEGRON FOR LOWER URINARY TRACT SYMPTOMS
This application relates to pharmaceutical compositions, comprising solabegron that are useful for the treatment of lower urinary tract symptoms such as, for...
2016/0158175 CITRATE RESORPTION OF BONE AS A TREATMENT FOR SPINAL STENOSIS
Spinal stenosis is a common debilitating illness that produces symptoms of neurogenic claudication, radiculopathy and weakness. Present therapies include...
2016/0158174 Enteric-Coated Functional Food Ingredients And Methods For Making The Enteric-Coated Functional Food Ingredients
Functional food ingredients for delivery to the gastrointestinal tract are delivered. Food products, nutraceuticals, and pharmaceuticals comprising the...
2016/0158173 METHODS FOR TREATING BRAIN INJURY
The treatment options for treating blast-induced and noise-induced traumatic brain injury and tinnitus are limited. Thus, the current invention provides...
2016/0158172 PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH...
Compounds, compositions and methods for the treatment of retinal degenerative diseases, such as retinitis pigmentosa, Leber's congenital Amaurosis, Syndromic...
2016/0158171 METHOD FOR TREATING INFLAMMATION AND PAIN
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and .omega.-(methylsulfonyl)alkylamine or...
2016/0158170 Delayed Release Cysteamine Bead Formulation, And Methods Of Making And Using Same
An enteric-coated bead dosage form of cysteamine, and related methods of manufacture and use, are disclosed.
2016/0158169 Antimicrobial Compositions with Cysteamine
The invention relates to products comprising an antibiotic agent and a second agent being a dispersant or an anti-adhesive agent, in particular a mucolytic...
2016/0158168 METHODS FOR THE BIOSYNTHESIS OF TAURINE OR HYPOTAURINE IN CELLS
The present invention describes an approach to increase taurine or hypotaurine production in prokaryotes. More particularly, the invention relates to genetic...
2016/0158167 THERAPEUTIC AGENTS FOR USE IN THE PROPYLAXIS AND/OR TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS
(RS)-[2-(3,4-dimethoxyphenyl)ethyl][2-hydroxy-3-(3-methylphenoxy)propylla- mine having the formula (IA), or a pharmaceutically acceptable salt thereof for the...
2016/0158166 METHODS OF REDUCING BRAIN CELL APOPTOSIS
A method of reducing the occurrence of brain cell damage or death caused by transient cerebral hypoxia/ischemia condition or a traumatic brain injury (TBI)...
2016/0158165 Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders
The present invention relates to combination therapies for treating Alzheimer's disease or an amyloidosis-associated pathological condition comprising...
2016/0158164 PTEROSTILBENE (PTER) FOR USE IN THE PREVENTION AND/OR TREATMENT OF SKIN DISEASES, DAMAGES OR INJURIES
The present invention refers to the use of PTER, or any acceptable salt thereof, optionally in combination with QUER, or any acceptable salt thereof, for the...
2016/0158163 Method For Treating Gefitinib-Resistant Non-Small-Cell Lung Cancer
The present invention relates to a method for treating gefitinib-resistant non-small-cell lung cancer (NSCLC) comprising administering an effective amount of a...
2016/0158162 PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES
The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the...
2016/0158161 PLASTER CONTAINING FENTANYL
A process for producing an adhesive matrix for a transdermal therapeutic system comprising a cover layer, the adhesive matrix, and a removable protective...
2016/0158160 NANOFIBROUS MATERIALS AS DRUG, PROTEIN, OR GENETIC RELEASE VEHICLES
The present invention is a bioactive, nanofibrous material construct which is manufactured using a unique electrospinning perfusion methodology. One embodiment...
2016/0158159 PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a...
2016/0158158 Encased Tamper Resistant Controlled Release Dosage Forms
In certain embodiments, the present invention is directed to a solid controlled release dosage form comprising: a core comprising a first portion of an opioid...
2016/0158157 ANTI-TUBERCULOSIS STABLE PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET COMPRISING GRANULES OF...
The present invention relates to an oral pharmaceutical fixed dose composition for use in the treatment of tuberculosis, said oral pharmaceutical composition...
2016/0158156 HEAT-STABLE DRY POWDER PHARMACEUTICAL COMPOSITIONS AND METHODS
Disclosed herein are heat-stable dry powders which include peptides or protein such as oxytocin for use as a pharmaceutical composition. The composition is...
2016/0158155 MAGNETIC NANOPARTICLES USEFUL FOR MAGNETIC SENSOR DETECTION ESPECIALLY IN BIOSENSOR APPLICATIONS
Disclosed is process for preparing magnetic nanoparticles (MNPs) that results in very sensitive MNPs that can be used in a variety of diagnostic and analytical...
2016/0158154 PROTEIN VESICLES AND METHODS OF MAKING AND USING THEREOF
Hollow, protein vesicles are provided. The protein vesicles can be loaded with desired cargo to be delivered to a subject, for example a human. One embodiment...
2016/0158153 MULTICOMPARTMENTAL LIPID NANOPARTICLES
The present invention relates to novel multicompartmental lipid nanoparticles (or cellisomes) with excellent stability comprising a first lipophilic...
2016/0158152 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIMINUTION OF BONE TISSUE
A method for prevention and/or treatment of diminution of bone tissue using a composition comprising a compound selected from Withaferin A (WFA), Withanolide...
2016/0158151 ON DEMAND VESICLE FORMATION FROM VESICLE PRECURSORS SUITABLE FOR LONG-TERM STORAGE
Disclosed is a water-in-oil-in-water (W/O/W) double emulsion including a first water phase, an oil phase and a second water phase, wherein the W/O/W double...
2016/0158150 Manufacture of Pharmaceutical Compositions
The present invention relates to particles and to methods of making particles. In particular, the invention relates to methods of making composite active...
2016/0158149 Inhalable Pharmaceutical Compositions and the Inhaler Devices Containing Them
A pharmaceutical composition suitable for use in a dry powder inhaler comprising 70 mass %-99.5 mass % of pharmaceutically acceptable carrier suitable for use...
2016/0158148 METHOD FOR TREATING A PERIODONTAL DISEASE
A method for treating a periodontal disease affecting a periodontal pocket of a patient. The method comprises inserting an oral delivery device into the...
2016/0158147 COMPOSITION AND METHOD FOR ORALLY ADMINISTERING ONE OR MORE ACTIVE AGENTS TO A PET
A composition and method for administering an active agent to a pet, such as a dog, a cat or a horse. The composition may comprise a yogurt-based chewable...
2016/0158146 OCULAR THERAPEUTIC AGENT DELIVERY DEVICES AND METHODS FOR MAKING AND USING SUCH DEVICES
Ocular implant devices (10, 20, 121) for the delivery of a therapeutic agent to an eye (101, 301) in a controlled and sustained manner. Dual mode and single...
2016/0158145 Container
The present invention relates to a container for an analyte-sensitive gel. When analyte contacts such a gel it causes a gel-sol transition resulting in...
2016/0158144 COSMETIC COMPOSITIONS
Disclosed are compositions and methods that can be used to improve the skin's visual appearance. In certain aspects, the compositions disclosed herein can...
2016/0158143 COSMETIC COMPOSITIONS
Disclosed are compositions and methods for their use that include a combination of Rhododendron ferrugineum (alpine rose) extract, Oenothera biennis (evening...
2016/0158142 BLEACHING AGENT CONTAINING POLYMERS
An agent for lightening keratin fibers, which, with regard to its weight, includes 20 to 75 wt. % of oil(s), 0.05 to 5 wt. % of polymer(s) from the group of...
2016/0158141 FOAMING BLEACH-BLONDING COMPOSITIONS
Agents for lightening keratinic fibers, which include, based on their weight, 20 to 75% by weight of oil(s), 0.05 to 5% by weight of polymer(s) from the group...
2016/0158140 CROSS-LINKED HYALURONIC ACID, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN THE AESTHETIC FIELD
The present invention relates, in one aspect, to the use as dermal filler of a cross-linked biopolymer compatible with the tissues of the human organism based...
2016/0158139 Compositions Comprising A Sirt6 Activator And A DNA Repair Enzyme
Compositions of the invention comprise 8-oxoguanine glycosylase (OGG1) and SIRT6 activating peptide G-A-G-V-S-A-E-NH.sub.2. Compositions of the invention...
2016/0158138 KERATIN-BASED HAIR STRAIGHTENING FORMULATIONS, METHODS AND SYSTEMS
The present invention teaches a hair straightening system including formulations that will safely and effectively straighten curly hair for at least 2-3 months...
2016/0158137 HAIR TREATMENT SYSTEMS AND METHODS USING PEPTIDES AND OTHER COMPOSITIONS
The present invention generally relates to compositions and methods for transdermal delivery, and treatment of hair related conditions. The compositions can be...
2016/0158136 COMPOSITION FOR REDUCTION OF TRPA1 AND TRPV1 SENSATIONS
A personal care composition and method of using a personal care composition having menthol and/or hydrogen peroxide and a TRPA1 and/or TRPV1 receptor antagonists.
2016/0158135 COMPOSITION FOR HAIR FRIZZ REDUCTION
A composition directed to a rinse-off composition for hair frizz reduction comprising from about 0.2% to about 20.0% of a moisture control material or mixture...
2016/0158134 Stable Vitamin C System
The present compositions include substantially anhydrous lotions, gels, or cremes having a high vitamin C content. The compositions described herein may be...
2016/0158133 PRIMECOAT COMPOSITIONS FOR PROTEINACEOUS SUBSTRATES AND METHODS OF PRIMING PROTEINACEOUS SUBSTRATES THEREWITH
Compositions containing a solution of a polyfunctional aziridine component in a non-reactive solvent, and methods of applying such compositions to...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.